Thursday, July 20, 2017 12:18:08 PM
Debunking phony "facts" about Omni - Omni is profitable and not diluting
More phony "facts" about omni debunked – Omni outperforms most independent pharmacies
Andrey didn't profit from preferred conversions
Omni is undervalued and should be trading at $.05 to $.13 per share
Omni owns Celebcream, its website and exclusive distribution rights – the location of Malecon pharmacy is a competitive advantage
The anti-aging cream market is estimated to be worth $191.7 billion by 2019
Debunked Again
Les
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM